Ohio State Navbar

Dr. Carbone on Genetic Testing Availability and Accuracy


David P. Carbone, MD, PhD, a professor in the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center, describes variations in the accuracy and availability of genetic testing technologies for patients with lung cancer. Across the country, there is not only uneven access to genetic testing but also variations in accuracy, explains Carbone. Each test for EGFR is not the same, since some exclude rare mutations. As such, there is currently a transition under way in genetic testing with a potential transition to next-generation sequencing in the future.

OncLive